These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27180825)
1. In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes. Dong D; Zhang T; Lu D; Liu J; Wu B Xenobiotica; 2017 Apr; 47(4):277-283. PubMed ID: 27180825 [TBL] [Abstract][Full Text] [Related]
2. Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients. Wang LZ; Ramírez J; Yeo W; Chan MY; Thuya WL; Lau JY; Wan SC; Wong AL; Zee YK; Lim R; Lee SC; Ho PC; Lee HS; Chan A; Ansher S; Ratain MJ; Goh BC PLoS One; 2013; 8(1):e54522. PubMed ID: 23382909 [TBL] [Abstract][Full Text] [Related]
3. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261 [TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542 [TBL] [Abstract][Full Text] [Related]
5. Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1. Wang L; Chan CEL; Wong AL; Wong FC; Lim SW; Chinnathambi A; Alharbi SA; Lee LS; Soo R; Yong WP; Lee SC; Ho PC; Sethi G; Goh BC Oncotarget; 2017 Jun; 8(25):41572-41581. PubMed ID: 28157715 [TBL] [Abstract][Full Text] [Related]
7. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534 [TBL] [Abstract][Full Text] [Related]
8. Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes. Liu H; Wu Z; Ma Z; Wu B Biopharm Drug Dispos; 2014 Dec; 35(9):513-24. PubMed ID: 25099990 [TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences. Sun H; Wang H; Liu H; Zhang X; Wu B Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1325-36. PubMed ID: 25219630 [TBL] [Abstract][Full Text] [Related]
10. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935 [TBL] [Abstract][Full Text] [Related]
11. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver. Mano Y; Usui T; Kamimura H Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571 [TBL] [Abstract][Full Text] [Related]
12. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin. Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805 [TBL] [Abstract][Full Text] [Related]
14. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842 [TBL] [Abstract][Full Text] [Related]
15. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform. Kaji H; Kume T Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137 [TBL] [Abstract][Full Text] [Related]
16. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. Fujiwara R; Nakajima M; Oda S; Yamanaka H; Ikushiro S; Sakaki T; Yokoi T J Pharm Sci; 2010 Jan; 99(1):442-54. PubMed ID: 19475557 [TBL] [Abstract][Full Text] [Related]
17. Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Ohno S; Kawana K; Nakajin S Drug Metab Dispos; 2008 Apr; 36(4):688-94. PubMed ID: 18187562 [TBL] [Abstract][Full Text] [Related]
18. Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. Wu Z; Liu H; Wu B J Pharm Pharmacol; 2015 Apr; 67(4):583-96. PubMed ID: 25496264 [TBL] [Abstract][Full Text] [Related]
19. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions. Wang X; Wang Z; Wang Z; Chen X; Yin H; Jiang L; Cao J; Liu Y Toxicol Lett; 2021 Mar; 338():51-57. PubMed ID: 33290829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]